Somatosensory Disorders: Clinical Trials

25 trials for Somatosensory Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 3 recruiting, 2 unknown, 1 enrolling by invitation. 25 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 325Completed 17, Recruiting 3, Unknown 2, Enrolling by invitation 1, Terminated 1, Withdrawn 1
Phase 24Completed 2, Recruiting 2

Follow Somatosensory Disorders: new trials by email Literature Review of Somatosensory Disorders trials Research Report on Somatosensory Disorders

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
AXS-14 (esreboxetine) - Fibromyalgia
Phase 3Enrolling by invitationAxsome Therapeutics, Inc.3002026-04-292026-11-06
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
AXS-14 (Esreboxetine), Placebo - Fibromyalgia
Phase 3RecruitingAxsome Therapeutics, Inc.6202026-01-142026-11-10
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia
Phase 2 / Phase 3RecruitingBernardino Clavo, MD, PhD422025-02-072026-09-18
Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia
Phase 2 / Phase 3RecruitingBernardino Clavo, MD, PhD422025-02-072026-09-25
Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN
Acetyllevocarnitine Hydrochloride Tablets, Placebo - Diabetic Peripheral Neuropathy (DPN), Paresthesia
Phase 3CompletedHaisco Pharmaceutical Group Co., Ltd.5162020-07-232022-04-08
Using Intranasal Midazolam (INM) and Lidocaine for Uncooperative Children
Midazolam, Lidocaine-Midazolam, Placebo - Burning Nose
Phase 2 / Phase 3CompletedLatakia University632017-06-012018-11-05
Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study
Verum acupuncture - Colorectal Cancer
Phase 3UnknownTzu-Liang Chen322016-01-012016-04-21
Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet
Polyamines depleted diet, associating Polydol® cans and predefined menus low in polyamines - Neuropathy, Digestive Cancer System
Phase 3CompletedUniversity Hospital, Clermont-Ferrand802013-02-022017-07-11
Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache
Botulinum toxin type A, 0,9% saline - Headache, Allodynia
Phase 3CompletedFederal University of Bahia402010-12-012011-05-23
Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia
Ketamine, Saline - Pain, Hyperalgesia
Phase 3CompletedFederal University of São Paulo602010-09-012014-11-10
Effect of Opioids in Neuropathic Pain in Postherpetic Patients
Remifentanil - Neuralgia, Postherpetic
Phase 3UnknownMedical University of Vienna302010-08-012010-04-12
Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia
continuous ropivacaine preperitoneal infusion, intravenous lidocaine infusion, parenteral analgesia combining acetaminophen and morphine - Pain, Postoperative
Phase 3CompletedAssistance Publique - Hôpitaux de Paris952010-02-012014-01-22
Local Anesthetic Infusion and Sternotomy
Local anesthetic (Ropivacaine), Saline - Hyperalgesia, Pain
Phase 3TerminatedUniversity Hospital, Bordeaux212009-02-012011-12-13
Local Anesthetic Infiltration to Prevent Postoperative Pain After Lumbar Surgery
Ropivacaine / Placebo - Hyperalgesia
Phase 3CompletedUniversity Hospital, Bordeaux502009-01-012026-05-19
Pain Medicine for Wound Care Procedures
Morphine plus Ketamine, Morphine plus Saline (placebo) - Wound Care, Pain Intensity
Phase 3CompletedUniversity of California, San Francisco122008-06-012024-03-26
Epidural Clonidine for Postoperative Hyperalgesia
Clonidine - Postoperative Hyperalgesia
Phase 3WithdrawnCambridge University Hospitals NHS Foundation Trust2007-12-012014-01-08
Effects of Nefopam on Hyperalgesia After Cardiac Surgery
Nefopam, néfopam, Placebo comparator - Hyperalgesia, Pain, Postoperative
Phase 2 / Phase 3CompletedUniversity Hospital, Bordeaux902006-12-012010-05-28
Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures
Phentolamine Mesylate (NV-101) - Anesthesia, Dental
Phase 3CompletedNovalar Pharmaceuticals, Inc.2402006-02-012006-11-17
Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures
Phentolamine Mesylate (NV-101) - Anesthesia, Dental
Phase 3CompletedNovalar Pharmaceuticals, Inc.2402006-02-012006-11-17
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
Xaliproden (SR57746A), Placebo, Oxaliplatin - Metastases, Colorectal Neoplasms
Phase 3CompletedSanofi8792005-12-012016-05-04

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Hyperalgesia (14)  ·  Paresthesia (9)  ·  Pain (8)  ·  Hypesthesia (5)  ·  Pain, Postoperative (4)  ·  Colorectal Neoplasms (3)  ·  Neoplasm Metastasis (3)  ·  Neurotoxicity Syndromes (3)  ·  Anxiety Disorders (2)  ·  Depression (2)  ·  Fibromyalgia (2)  ·  Peripheral Nervous System Diseases (2)  ·  Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Bronchiolitis Obliterans Syndrome (1)

Broader conditions

Nervous System Diseases (25)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Sensation Disorders (25)  ·  Signs and Symptoms (25)  ·  Neurologic Manifestations (24)  ·  Pathologic Processes (8)  ·  Neuromuscular Diseases (6)  ·  Neoplasms by Site (5)  ·  Digestive System Diseases (4)  ·  Neoplasms (4)  ·  Postoperative Complications (4)  ·  Chemically-Induced Disorders (3)  ·  Colonic Diseases (3)  ·  Digestive System Neoplasms (3)

Interventions

Sodium Chloride (3)  ·  Ketamine (2)  ·  Morphine (2)  ·  Oxygen (2)  ·  Phentolamine (2)  ·  Ropivacaine (2)  ·  esreboxetine (2)  ·  xaliproden (2)  ·  2,2'-dithiodiethanesulfonic acid (1)  ·  Anesthetics, Local (1)  ·  Botulinum Toxins, Type A (1)  ·  Clonidine (1)  ·  Fentanyl (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)

Sponsors

University Hospital, Bordeaux (3)  ·  Axsome Therapeutics, Inc. (2)  ·  Bernardino Clavo, MD, PhD (2)  ·  Novalar Pharmaceuticals, Inc. (2)  ·  Sanofi (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  BioNumerik Pharmaceuticals, Inc. (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Federal University of Bahia (1)  ·  Federal University of São Paulo (1)  ·  Haisco Pharmaceutical Group Co., Ltd. (1)  ·  Jazz Pharmaceuticals (1)  ·  Latakia University (1)  ·  Medical University of Vienna (1)  ·  National Center for Research Resources (NCRR) (1)

Countries

United States (6)  ·  France (5)  ·  Brazil (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Norway (1)

Top investigators

Athena Papas, DMD (2)  ·  Bernardino Clavo, MD, PhD (2)  ·  Anthony Absalom, MBBS MD FRCA (1)  ·  Himar Fabelo, BSc, PhD (1)  ·  Jacob Lorenzo-Morales, Prof (1)

Results publications

PMID 30679026, PMID 31378656, PMID 36606664, PMID 10691234, PMID 10910490, PMID 12826855, PMID 15317861, PMID 15983467, PMID 16508405, PMID 18806023, PMID 21436683, PMID 23063945, PMID 24420962, PMID 25833669, PMID 27739142, PMID 41572235

NIH funding

2008 (1)